Page 19 - JCTR-9-5

Ji et al. | Journal of Clinical and Translational Research 2023; 9(5): 317-321 321
Role of Inhaler Devices. Respir Med 2017;124:6-14. Plus Flow-vu Spacers in Young Children with Asthma.
[10] Lawford P, McKenzie D, Alston D. The Effect of an J Asthma 2015;52:301-7.
Aerochamber on Bronchodilator Response to a Metered- [20] Burudpakdee C, Kushnarev V, Coppolo D, Suggett JA.
dose Inhaler. Practitioner 1982;226:2093-5. A Retrospective Study of the Effectiveness of the
®
®
[11] Nicola M, Hussein RR, Soliman YM, Abdelrahim M. Effect AeroChamber Plus( ) Flow-vu( ) Antistatic Valved
of Different Accessory Devices on the Dose Delivered Holding Chamber for Asthma Control. Pulm Ther
from Pressurised Metred-dose Inhalers. Int J Clin Pract 2017;3:283-96.
2021;75:e14157. [21] Dissanayake S, Suggett J. A Review of the in vitro and in
[12] Barjaktarevic I, Kaner R, Buhr RG, Cooper CB. vivo Valved Holding Chamber (VHC) Literature with a
Bronchodilator Responsiveness or Reversibility in Asthma Focus on the AeroChamber Plus Flow-vu Anti-static VHC.
and COPD-a Need for Clarity. Int J Chron Obstruct Pulmon Ther Adv Respir Dis 2018;12:1753465817751346.
Dis 2018;13:3511-3. [22] Wachtel H, Nagel M, Engel M, El Azzi G, Sharma A,
[13] Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Suggett J. In vitro and Clinical Characterization of the
®
®
Cooper BG, Hall GL, et al. Standardization of Spirometry Valved Holding Chamber AeroChamber Plus( ) Flow-vu( )
®
2019 Update. An Official American Thoracic Society and for Administrating Tiotropium Respimat( ) in 1-5-year-
European Respiratory Society Technical Statement. Am J old Children with Persistent Asthmatic Symptoms. Respir
Respir Crit Care Med 2019;200:e70-88. Med 2018;137:181-90.
[14] Lee J, Koh D, Ong CN. Statistical Evaluation of Agreement [23] Fakih F, Spangenthal S, Sigal B, Darken P, Maes A,
Siddiqui S, et al. Randomized Study of the Effects
between Two Methods for Measuring a Quantitative of Aerochamber Plus( ) Flow-vu( ) on the Efficacy,
®
®
Variable. Comput Biol Med 1989;19:61-70. Pharmacokinetics and Safety of Glycopyrronium/
[15] Bland JM, Altman DG. A Note on the Use of the Formoterol Fumarate Dihydrate Metered Dose Inhaler in
Intraclass Correlation Coefficient in the Evaluation of Patients with Chronic Obstructive Pulmonary Disease.
Agreement between Two Methods of Measurement. Respir Med 2018;138:74-80.
Comput Biol Med 1990;20:337-40. [24] Nicola M, Soliman YM, Hussein R, Saeed H, Abdelrahim M.
[16] Crimi N, Palermo F, Cacopardo B, Vancheri C, Oliveri R, Comparison between Traditional and Nontraditional Add-
Palermo B, et al. Bronchodilator Effect of Aerochamber on Devices Used with Pressurised Metered-dose Inhalers.
and Inspirease in Comparison with Metered Dose Inhaler. ERJ Open Res 2020;6:00073-2020.
Eur J Respir Dis 1987;71:153-7. [25] Tordera MP, Viejo JL, Sanchis J, Badia X, Cobos N,
[17] Nelson HS, Loffert DT. Comparison of the Bronchodilator Picado C, et al. Assessment of Patient Satisfaction and
Response to Albuterol Administered by the OptiHaler, the Preferences with Inhalers in Asthma with the FSI-10
AeroChamber, or by Metered Dose Inhaler Alone. Ann Questionnaire. Arch Bronconeumol 2008;44:346-52.
Allergy 1994;72:337-40. [26] Zervas E, Samitas K, Gaga M. Assessment of Satisfaction
[18] Prabhakaran S, Shuster J, Chesrown S, Hendeles L. with Different Dry Powder Inhalation Devices in Greek
Response to Albuterol MDI Delivered through an Anti- Patients with COPD and Asthma: The ANASA Study. Int J
static Chamber During Nocturnal Bronchospasm. Respir Chron Obstruct Pulmon Dis 2016;11:1845-55.
Care 2012;57:1291-6. [27] Plaza V, Giner J, Curto E, Alonso-Ortiz MB, Orue MI,
[19] Ammari WG, Toor S, Chetcuti P, Stephenson J, Chrystyn H. Vega JM, et al. Determinants and Differences in
Evaluation of Asthma Control, Parents’ Quality of Life and Satisfaction with the Inhaler among Patients with Asthma
Preference between AeroChamber Plus and AeroChamber or COPD. J Allergy Clin Immunol Pract 2020;8:645-53.

Publisher’s note
AccScience Publishing remains neutral with regard to jurisdictional
claims in published maps and institutional affiliations.
DOI: http://dx.doi.org/10.18053/jctres.09.202305.23-00081